Senior Director, Team Lead, CDK4/6 Portfolio, US Breast Cancer (AI)
Контакты
230 900 - 384 800$
Формат работы
hybrid
Тип работы
fulltime
Грейд
director
Английский
b2
Страна
US
aibrand managementp&l managementpeople managementoncologycommercial strategyadvanced analyticspharmaceutical marketingpatient marketingbreast cancer
Вакансия из Hirify Global, списка международных tech-компаний Для мэтча и отклика нужен Plus
Пожаловаться
Зарплата и рынок
развернуть
$231к-385к/год
$200к$220кмедиана$240к
По похожим ролям (50) ~ $220к/год
89
Крутая вакансия
развернуть
Чётко описанная руководящая роль в крупной фармкомпании: ответственность за переход онкологического портфеля и конкретные задачи по P&L и управлению командой. При этом работа предполагает высокий темп и поездки.
Высокая нагрузка
Широкая ответственность
Онкологическое направление
Мэтч & Сопровод
Для мэтча с этой вакансией нужен Plus
Подключить Plus
Описание вакансии
Текст:
Hirify AI/Оригинал
TL;DR
Senior Director, Team Lead, CDK4/6 Portfolio, US Breast Cancer (AI): Leading the integrated IBRANCE and atirmociclib commercial strategy, including P&L ownership, portfolio transition, launch readiness, and a team of 6–8 marketers with an accent on oncology brand strategy, patient engagement, and AI-enabled analytics. Focus on optimizing IBRANCE through IRA and loss of exclusivity, building atirmociclib launch readiness, and aligning cross-functional teams around complex customer, access, and investment decisions.
Location: Hybrid role requiring 2 to 3 days per week on site in New York City, NY, or Collegeville, PA, United States. Travel of up to 25% may be required. Permanent work authorization in the United States is required.
Annual base salary: $230,900–$384,800, plus a 25% bonus target and eligibility for a share-based long-term incentive program.
Company
hirify.global develops and commercializes medicines, with this role supporting its Commercial Oncology business and breast cancer portfolio.
What you will do
Own IBRANCE P&L management, forecasting, OpEx, resource allocation, ROI optimization, and the loss-of-exclusivity strategy.
Build atirmociclib launch readiness and a multi-year strategy across frontline and early breast cancer indications.
Lead US HCP, account, pricing, contracting, channel, distribution, patient, advocacy, and market-shaping strategies.
Use customer insights, advanced analytics, AI, and omnichannel engagement to improve marketing impact and commercial decisions.
Lead the integrated transition from IBRANCE to atirmociclib across customers, accounts, field teams, and portfolio assets.
Manage, coach, and develop 6–8 Director- and Senior Manager-level HCP and patient marketers.
Requirements
Bachelor’s degree and 12+ years of pharmaceutical industry experience, or a Master’s degree and 10+ years.
Pharmaceutical or biotech commercial experience, including US brand management and P&L accountability.
Deep understanding of US market dynamics, specialty channels, oncology organized customers, and payers.
Demonstrated use of AI and advanced analytics for customer insight, targeting, forecasting, and investment decisions.
Success developing, executing, and measuring complex marketing programs and translating customer needs and insights into strategy and tactics.
5+ years of direct or matrix management or coaching of marketing colleagues from Manager to Director level.
Ability to influence and collaborate across functions, engage senior executives, analyze complex data, and communicate effectively.
Permanent US work authorization is required.
Nice to have
Oncology marketing experience.
Experience managing a brand through loss of exclusivity.
Experience leading a US oncology or specialty product launch from pre-launch market shaping through first-line commercialization.
Experience with omnichannel or AI-enabled customer engagement, hybrid field/digital coverage, account-based approaches, or other go-to-market models.
Experience leading patient marketing, direct-to-patient, patient support, adherence, and advocacy programs.
Culture & Benefits
Fast-paced environment requiring complex decisions, data synthesis, and attention to detail.
Collaboration across scientific, medical, manufacturing, commercial, and cross-functional Oncology teams.
Hybrid work arrangement with 2 to 3 on-site days per week and domestic and international travel for congresses, sales meetings, and customer interactions.
Benefits include a 401(k) with company contributions, retirement savings contributions, paid vacation and leave, caregiver and medical leave, and medical, prescription, dental, and vision coverage.
Relocation package eligibility is listed as unavailable, although relocation assistance may be available based on business needs or eligibility.
Hiring process
The last date to apply is November 30, 2026.
Applicants should review hirify.global’s guidelines for acceptable and prohibited AI use during recruitment.
Будьте осторожны
Если работодатель просит войти в их систему, используя iCloud/Google, прислать код/пароль, запустить код/ПО, не делайте этого. Это мошенники. Обязательно жмите «Пожаловаться» или пишите в поддержку. Подробнее в гайде →